abstract |
Herein are described uses of a compound of the formula (II): or a pharmaceutically acceptable salt, hydrate, or solvate of said compound, for treating or improving at least one disorder or parameter of sleep in a subject, wherein said compound is for use at a dose of between 0.1 mg and 128 mg. Compositions for use in said treatment are also described. |